Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G VivasAntenatal care — maternal medicine

O&G Vivas · Antenatal care — maternal medicine

Preeclampsia diagnosis and management — structured oral station (12 minutes)

FRANZCOG oral-format station on preterm preeclampsia at 30 weeks: the inpatient surveillance plan, magnesium indications, angiogenic biomarkers interpreted correctly with Zeisler and PARROT, fullPIERS for prognosis, escalation on deterioration with named drugs and doses, and shared decision-making about birth before 34 weeks. Scored against the eight published RANZCOG oral domains.

clinical5 min readSource-verified ·

Target exams

FRANZCOGMRCOGABOG
On this page
Study tools

Target exams

FRANZCOGMRCOGABOG
Prompt
You are the obstetric registrar covering birth suite in a tertiary unit. A 30-year-old G2P1 at 30+2 weeks has been admitted from the day unit with a blood pressure of 158/104 mmHg, a protein:creatinine ratio of 64 mg/mmol, and a two-day history of headache. She is on labetalol 200 mg three times daily. Her estimated fetal weight is on the 8th centile with a raised umbilical artery pulsatility index and present end-diastolic flow. Bloods on admission: platelets 142 x 10^9/L, ALT 34 IU/L, creatinine 71 micromol/L. The examiner will ask you to set out her inpatient plan, then probe your monitoring, your use of biomarkers, your response to deterioration and your counselling about birth at this gestation.

Station format

Four minutes reading, twelve minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply: history and examination; investigations and interpreting results; treatment and management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport with patient, support person or colleague; respect; and communication skills. [3]

Reveal the examiner script and model responsesShowHide

Opening prompt — "Set out her inpatient plan."

Model response — say it as a plan with numbers. [1][2]

  • "This is preeclampsia at 30+2 weeks with uteroplacental dysfunction — she meets ISSHP 2021 on proteinuria at 64 mg/mmol and again on fetal growth restriction with an abnormal umbilical artery Doppler. She is not currently in the severe range and her bloods are not yet deranged."[1]
  • "Admit to a high-dependency antenatal area. Blood pressure four-hourly or more often, daily symptom review, strict fluid balance, and a defined escalation trigger written in the notes."[2][3]
  • "Antihypertensives: she is on labetalol three times daily. I would uptitrate per the current protocol toward the local ceiling, and add nifedipine modified release per protocol if she remains above target."[3][2]
  • "Corticosteroids: betamethasone per the current protocol dosing, because birth within seven days is plausible at this gestation."[9]
  • "Bloods every 24 to 48 hours, and immediately with any new symptom: full blood count, creatinine and electrolytes, liver enzymes, urate, lactate dehydrogenase, and repeat protein:creatinine ratio."[1][2]
  • "Fetal surveillance: daily or alternate-day cardiotocography, umbilical artery Doppler twice weekly given the raised pulsatility index, and growth reassessed in two weeks."[1][3]
  • "And I would ask neonatology to meet her and her partner now, not on the day she delivers."[3]

Examiner is listening for: the ISSHP criteria named, a drug uptitration with numbers, steroids, a monitoring interval, and early neonatal involvement. [1]

Probe 1 — "Would you give magnesium sulfate today?"

  • "Not today. Her blood pressure is not in the severe range and she has no neurological features beyond a headache that has not escalated. ISSHP and SOMANZ support magnesium where eclampsia risk is judged high — severe hypertension or neurological signs — and it is mandatory once she has seized."[1][3]
  • "I would have the threshold explicit in her notes: severe-range blood pressure, worsening headache, visual disturbance, clonus, epigastric pain or a decision to deliver. At that point, magnesium per the current protocol loading and maintenance doses, continued 24 hours after birth or the last seizure, whichever is later."[8][3]
  • "The evidence is Magpie: 10,141 women, eclampsia cut by 58%, from 1.9% to 0.8%, with a probable reduction in maternal death."[8]

Probe 2 — "Her placental growth factor comes back low and the sFlt-1:PlGF ratio is 210. How does that change things?"

  • "Angiogenic markers are best understood as rule-out and triage tools, not as a trigger for delivery on their own. Zeisler showed a ratio of 38 or lower has a negative predictive value of 99.3% for not developing preeclampsia within a week; a ratio above 38 has a positive predictive value of only 36.7% for preeclampsia within four weeks."[4]
  • "In her case the diagnosis is already made clinically, so a high ratio does not diagnose anything new. What it does is mark her as high risk for progression and justify the intensity of surveillance I have set out."[4][5]
  • "PARROT showed that revealing placental growth factor results cut the median time to clinical confirmation of preeclampsia from 4.1 days to 1.9 days and was associated with fewer maternal severe adverse outcomes. But PARROT-2 showed that repeat testing did not improve perinatal outcomes, so I would not test her serially by reflex."[5][6]

Probe 3 — "On day 4 her platelets have fallen, her transaminases have trebled, her creatinine has risen and her blood pressure is in the severe range. She is vomiting. What now?"

  • "Multi-organ deterioration with severe-range hypertension — platelets 96 x 10^9/L, ALT 118 IU/L, creatinine 98 micromol/L, blood pressure 176/116 mmHg. Treat the pressure within 30 to 60 minutes per the current protocol doses and ceilings."[2][1]
  • "Magnesium sulfate per the current protocol loading and maintenance doses, with hourly reflexes, respiratory rate and urine output, and calcium gluconate per protocol available as the antidote."[8][2]
  • "Restrict fluid per the current protocol rate, catheterise, and do not give a bolus for oliguria unless the creatinine is rising and I have excluded pulmonary oedema."[1][2]
  • "Deliver. At 30+4 weeks with a falling platelet count, rising transaminases, rising creatinine and uncontrolled hypertension, expectant management is no longer safe. I would apply fullPIERS to articulate that — gestational age, chest pain or dyspnoea, oxygen saturation, platelet count, creatinine and aspartate transaminase, area under the ROC curve 0.88 for adverse maternal outcomes within 48 hours."[7][2]
  • "Consultant, anaesthetist and neonatal team involved now; I would expect caesarean given the gestation, the growth restriction and an unfavourable cervix."[2][3]

Probe 4 — "Her partner asks why you cannot just wait until 34 weeks."

This is the communication and rapport domain. Answer him, not the examiner. [3][10]

  • Sit down, use their names, and check what they already understand.
  • "I know how much every extra week matters for your baby, and if it were safe I would give you those weeks. What has changed today is that her liver, her kidneys and her platelets are all being affected, and her blood pressure is at the level where we worry about a stroke."
  • "The only treatment that reverses this is delivering the baby. Waiting now risks her having a fit, a bleed into the brain, or the placenta separating — and none of those help the baby either."[2][1]
  • "The steroid injections she had on admission have already done most of their work for the baby's lungs. The neonatal team will meet you before we go to theatre."[9]
  • Pause, allow silence, invite questions, and offer a follow-up conversation after delivery.[3]

Probe 5 — "What happens after birth?"

  • "Continue magnesium for 24 hours, continue and expect to escalate antihypertensives around days 3 to 6 when blood pressure peaks, and repeat bloods until platelets and transaminases are clearly improving."[2][1]
  • "Choose breastfeeding-compatible agents — labetalol, nifedipine or enalapril — reassess venous thromboembolism prophylaxis once haemostasis is secure, and use non-steroidal anti-inflammatory drugs cautiously."[3][1]
  • "Then the follow-up: blood pressure at one to two weeks, full review with bloods and protein:creatinine ratio at six weeks, reclassification at 12 weeks, and a debrief plus a documented plan for the next pregnancy."[1][3]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References10ShowHide
  1. [1]Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice Pregnancy Hypertens, 2022.PMID 35066406
  2. [2]American College of Obstetricians and Gynecologists Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222 Obstet Gynecol, 2020.PMID 32443079
  3. [3]Shanmugalingam R, Barrett HL, Beech A, et al. A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline Med J Aust, 2024.PMID 38763516
  4. [4]Zeisler H, Llurba E, Chantraine F, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia N Engl J Med, 2016.PMID 26735990
  5. [5]Duhig KE, Myers J, Seed PT, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial Lancet, 2019.PMID 30948284
  6. [6]Hurrell A, Webster L, Sparkes J, et al. Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial Lancet, 2024.PMID 38342128
  7. [7]von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model Lancet, 2011.PMID 21185591
  8. [8]Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial Lancet, 2002.PMID 12057549
  9. [9]Roberts D, Brown J, Medley N, Dalziel SR Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth Cochrane Database Syst Rev, 2017.PMID 28321847
  10. [10]Chappell LC, Brocklehurst P, Green ME, et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial Lancet, 2019.PMID 31472930
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousHypertensive disorders of pregnancy — structured oral station (12 minutes)Antenatal care — maternal medicineNextPregestational diabetes — structured oral station (12 minutes)Antenatal care — maternal medicine